$242.95
By Andrew Teasdale
Learn to implement effective control measures for mutagenic impurities in pharmaceutical development
Mutagenic Impurities: Strategies for Identification and Control, authored by distinguished chemist Andrew Teasdale, offers a thorough examination of mutagenic impurities and their impact on the pharmaceutical industry. The book incorporates the adoption of the ICH M7 guideline and focuses on mutagenic impurities from both a toxicological and analytical perspective.
The editor has created a primary reference for any professional or student studying or working with mutagenic impurities and offers readers a definitive narrative of applicable guidelines and practical, tested solutions. It demonstrates the development of effective control measures, including chapters on the purge tool for risk assessment.
The book incorporates a discussion of N-Nitrosamines, which was arguably the largest mutagenic impurity issue ever faced by the pharmaceutical industry, resulting in the recall of Zantac and similar drugs due to N-Nitrosamine contamination.
Readers will also benefit from the inclusion of:
Perfect for chemists, analysts, and regulatory professionals, Mutagenic Impurities: Strategies for Identification and Control will also earn a place in the libraries of toxicologists and clinical safety scientists seeking a one-stop reference on the subject of mutagenic impurity identification and control.
Product Details
Publisher: Wiley
Publication Date: February 1, 2022
Language: English
ISBN: 9781119551218, 9781119551263
Language | |
---|---|
Author |
Fermentum tempor cubilia risus tellus massa dis consectetur dolor.
WhatsApp Chat Oniline